Strauss E

Language: English
References: 23
Page: 6-11
PDF size: 248.38 Kb.

Text Extraction

Schistosomiasis is an endemic disease of tropical areas. In American countries as Brazil, Venezuela, Puerto Rico, Antilles and Suriname the worm that causes schitosomiasis is the schistosoma mansoni. According to the World Health Orzganization more than 600 million people live in risk areas and about 200 million are infected in 75 countries.

REFERENCES

1. Lambertucci JR & Nobre V. Doença Hepática Esquistossomótica. IN Kalil AN, Coelho J, Strauss E. Fígado e Vias Biliares: Clínica e Cirurgia, Ed. Revinter, Rio de Janeiro, 2000: 349-364.

2. Abel L & Dessein A. Genetic predispositin to high infections in an endemic area of Schistosoma mansoni. Revista da Sociedade Brasileira de Medicina Tropical 1991; 24: 1-3.

3. Kravets D & Romero G. Fisiopatologia da Hipertensão Portal IN Gayotto LCC & Alves VAF Doenças do Fígado e Vias Biliares, Ed. Atheneu, São Paulo, 2000: 103-117.

4. Strauss E. Hipertensão Portal IN Matos AA & Dantas W. Compêndio de Hepatologia. Fundo Editorial Byk, 2ª ed. 2001: 625-655.

5. Camacho-Lobato L. & Borges DR. Early liver dysfunction in schistosomiasis. J Hepatology 1998; 29: 233-240.

6. Bassily S, Dunn MA, Farid Z, Kilpatrick ME, El Masry NA, Kamel IA, El Alamy M et al. Chronic hepatitis B in patients with schistosomiasis. J Trop Med Hyg 1983; 86: 67-71.

7. Strauss E. Hepatite e esquistossomose mansônica. IN Silva LC. Hepatites Agudas e Crônicas, Sarvier, São Paulo 2ª ed. 1995: 253-258.

8. Hyams KC, Mansour MM, Masoud A & dunn MA. Parenteral antischistosomal therapy: a potential risk factor for hepatitis B infection. J Med Virol 1987; 23: 109-114.

9. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-91.

10. Pereira LM, Melo MC, Saleh MG, Massarolo P, Koskinas J, Domingues AL, Spinelli V et al. Hepatitis C virus infection in schistosomiasis mansoni in Brazil. J Med Virol 1995; 45: 423-8.

11. Strauss E, Gayotto LCC, Antonelli R, Deperon S, Cabral GL & Raia S. Systemic surgical shunts and splenomegaly as causes of hemolysis in portal hypertension in mansonic schistosomiasis: evaluation through serum levels of haptoglobin, hemopexin and bilirubin. J Hepatology 1986; 2: 340-350.

12. Mies S, Braghirolli Neto O, Beer Jr A, Baía C, Alfieri Jr F, Pereira LMMB, Sette MJA et al. Systemic and hepatic hemodynamics in hepatosplenic Manson’s Schistosomiasis with and without propranolol. Dig Dis Sci 1997; 42: 751-61.

13. de Cleva R, Pugliese V, Zilberstein B, Saad WA, Pinotti HW, Laudanna AA. Estado hiperdinâmico sistêmico na forma hepatoesplênica da Esquistossomose mansônica. Rev Hosp Clin Fac Med São Paulo 1998; 53: 6-10.

14. Strauss E, Schimidt E, Raia S & Kieffer J. Intra-hepatic percutaneous deposition of radioxenon (133Xe) as a means of measuring hepatic blood flow. Acta Hepato-Gastroenterol 1980; 27: 99-103.

15. Cerri GG, Oliveira IRS & Machado MM. Hepatosplenic schistosomiasis: ultrasound evaluation update. Ultrasound Quarterly 1999; 15: 210-215.

16. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-354.

17. Braillon A, Moreau R, Hadengue A, Roulot D, Sayegh R, Lebrec D. Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol. J Hepatology 1989; 9: 312-318.

18. Strauss E, Lacet CM, Honain NZ, Santos WR, Tramonti R & Albano A. Partial results of a controlled randomized trial comparing propranolol and sclerotherapy for the treatment of portal. Dig Dis Sci 1986; 31: 131S.

19. Sarin SK, Groszmann RJ, Mosca PG, Rojkind M, Stadecker MJ, Bhatal R, Reuben A et al. Propranolol ameliorates the development of portal systemic shunting in a chronic murine schistosomiasis model of portal hypertension. J Clin Invest 1991; 87: 1032-36.

20. El Tourabi H, el Amin AA, Shaheen M, Woda AS, Homeida M, Harron DW. Propranolol reduces mortality in patients with portal hypertension secondary to schistosomiasis. Ann Trop Med Parasitol 1994; 88: 493-500.

21. Raia S, Mies S & Alfieri Jr. F-Portal hypertension in mansonic schistosomiasis. World J Surg 1991; 15: 176-187.

22. Strauss E. Hipertensão portal esquistossomótica: análise evolutiva de intercorrências clínicas, dados endoscópicos e laboratoriais em estudo randomizado comparando três tipos de cirurgia. Tese de Livre-Docência – Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, 1989.

23. Raia S, Silva LC, Gayotto LCC, Forster SC, Fukushima J & Strauss E. Portal hypertension in schitosomiasis: a long-term follow-up of a randomized trial comparing three types of surgery. Hepatology 1994; 20: 398-403.